09-07-2015 дата публикации
Номер: US20150191524A1
The use of model T cell receptors (TCRs) as scaffolds for in vitro engineering of novel specificities is provided. TCRs with de novo binding to a specific peptide-major histocompatibility complex (MHC) product can be isolated by: 1) mutagenizing a T cell receptor protein coding sequence to generate a variegated population of mutants (a library), 2) selection of the library of TCR mutants with the specific peptide-MHC, using a process of directed evolution and a “display” methodology (e.g., yeast, phage, mammalian cell) and the peptide-MHC ligand. The process can be repeated to identify TCR variants with improved affinity for the selecting peptide-MHC ligand. 1. A modified T cell receptor , or antigen binding fragment thereof , comprising a Vα and a Vβ derived from a wild type T cell receptor , wherein the Vα , the Vβ , or both , comprise a mutation in one or more complementarity determining regions (CDRs) relative to the wild type T cell receptor , wherein the modified T cell receptor binds to a non-cognate peptide-MHC not bound by the wild type T cell receptor.2. The modified T cell receptor of claim 1 , wherein the wild type T cell receptor comprises the Vα amino acid sequence set forth in SEQ ID NO:1 and the Vβ amino acid sequence set forth in SEQ ID NO:2.3. The modified T cell receptor of claim 2 , comprising a modified Vα comprising an amino acid sequence having at least 80% identity to the Vα amino acid sequence set forth in SEQ ID NO:1 and a modified Vβ comprising an amino acid sequence having at least 80% identity to the Vβ amino acid sequence set forth in SEQ ID NO:2 claim 2 , wherein the modified T cell receptor does not bind to the cognate peptide-MHC bound by the wild type T cell receptor.4. The modified T cell receptor of claim 2 , wherein the modified T cell receptor comprises an amino acid substitution at one or more of CDR1α 31 claim 2 , CDR3α 98 claim 2 , CDR3β 99 claim 2 , CDR3α 97 claim 2 , CDR3β 102 claim 2 , CDR3α 99 claim 2 , CDR3β 100 claim 2 ...
Подробнее